Strategy discussion of strengthening ECG monitoring in phase I clinical trials of investigational new drugs / 中国药学杂志
Chinese Pharmaceutical Journal
;
(24): 1153-1155, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-859547
ABSTRACT
OBJECTIVE:
To discuss the strategy of strengthening ECG monitoring in phase I study and to provide references for the necessity of thorough QT/QTc study and for the subsequent development strategies.METHODS:
Relevant progresses in cardiac safety studies and guidelines of QT/QTc study were referred to in discussing the study strategy.RESULTS:
The applicable scope, protocol design and quality control of the strengthening ECG monitoring study have been preliminarily explored.CONCLUSIONS:
Based on the phase I clinical trials, cardiac safety of the new drugs is preliminarily evaluated and screened, without increasing drug exposure, and this study during phase I clinical trial will provide basis and reference for the further QT/QTc trial.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
/
Practice guideline
Language:
Chinese
Journal:
Chinese Pharmaceutical Journal
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS